These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11733869)

  • 1. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes.
    D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
    Horm Metab Res; 2001 Nov; 33(11):664-9. PubMed ID: 11733869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
    D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
    Auton Neurosci; 2003 Mar; 104(2):88-94. PubMed ID: 12648610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA; da Silva CG; Costa RS; Coimbra TM
    Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TGF-beta/GLUT1 axis in susceptibility vs resistance to diabetic glomerulopathy in the Milan rat model.
    Ricci C; Iacobini C; Oddi G; Amadio L; Menini S; Rastaldi MP; Frasheri A; Pricci F; Pugliese F; Pugliese G
    Nephrol Dial Transplant; 2006 Jun; 21(6):1514-24. PubMed ID: 16449286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
    Russo LM; del Re E; Brown D; Lin HY
    Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats.
    Zhang YW; Xie D; Xia B; Zhen RT; Liu IM; Cheng JT
    Horm Metab Res; 2006 Feb; 38(2):82-8. PubMed ID: 16523407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of retinal GLUT1 in diabetes by ubiquitinylation.
    Fernandes R; Carvalho AL; Kumagai A; Seica R; Hosoya K; Terasaki T; Murta J; Pereira P; Faro C
    Mol Vis; 2004 Aug; 10():618-28. PubMed ID: 15359219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
    Liu IM; Tzeng TF; Liou SS; Chang CJ
    J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats.
    Paczek L; Gaciong Z; Bartlomiejczyk I; Sebekova K; Birkenmeier G; Heidland A
    Drugs Exp Clin Res; 2001; 27(4):141-9. PubMed ID: 11822224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urinary TGF-beta1 and cortical renal GLUT1 and GLUT2 levels: additive effects of hypertension and diabetes.
    Schaan BD; Irigoyen MC; Bertoluci MC; Lima NG; Passaglia J; Hermes E; Oliveira FR; Okamoto M; Machado UF
    Nephron Physiol; 2005; 100(3):p43-50. PubMed ID: 15855808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy.
    Cojocel C; Al-Maghrebi M; Thomson MS; Rawoot P; Raghupathy R
    Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
    Zuo Y; Gu Y; Ma J; Lin S
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic modulation of the renal glucose transporter GLUT2 in diabetic rats.
    Schaan BD; Irigoyen MC; Lacchini S; Moreira ED; Schmid H; Machado UF
    Auton Neurosci; 2005 Jan; 117(1):54-61. PubMed ID: 15620570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation of the expression and function of glucose transporter-1 by TGF-beta 1 and high glucose in mesangial cells].
    Zhang J; Liu Z; Liu H; Li Y; Li L
    Chin Med J (Engl); 2000 Jun; 113(6):508-13. PubMed ID: 11775867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.